The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial.
Blood. 2021 Dec 2;138(22):2173-2184. doi: 10.1182/blood.2021011725.
Blood. 2021.
PMID: 34086880
Clinical Trial.